Showing results (301-310 of 715) with videos related to
Sort By:
Pageof 72
Journal of Virology|May 30, 2006
Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responsesSteven G Deeks, Becky Schweighardt, Terri Wrin, et al.AIDS (London, England)|November 12, 2014
Gut epithelial barrier and systemic inflammation during chronic HIV infectionMa Somsouk, Jacob D Estes, Claire Deleage, et al.Virology|January 13, 2006
CD8 T cell effector maturation in HIV-1-infected childrenKimberly A Jordan, Scott N Furlan, Veronica D Gonzalez, et al.AIDS (London, England)|April 23, 2008
Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertensionPriscilla Y Hsue, Steven G Deeks, Husam H Farah, et al.Antiviral Therapy|June 25, 2008
Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 originRichard W Price, Robin Parham, Jing Lu Kroll, et al.AIDS (London, England)|July 1, 2014
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in AfricaMaya L Petersen, Linh Tran, Elvin H Geng, et al.The Journal of Infectious Diseases|February 5, 2021
Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex With MenRaquel Ron, Alfonso Cabello, María José Gosalbes, et al.Journal of the Pediatric Infectious Diseases Society|November 28, 2025
Weight Gain Among Children and Adolescents on Dolutegravir in SpainBlanca Bravo-Queipo-de-Llano, Luis Manuel Prieto Tato, Antoni Noguera-Julian, et al.Infectious Diseases of Poverty|March 6, 2026
Towards tuberculosis elimination in people with HIV on antiretroviral therapy: evidence from a two-decade nationwide cohort in SpainRoser Navarro-Soler, Alfonso Muriel, Chiara Fanciulli, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 8, 2025
Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIVErick De La Torre Tarazona, Sergio Calderón-Vicente, María Fons-Contreras, et al.Pageof 72